By |

Profile

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. The company's pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat.

Contact Information

Website: www.4sc.com
Email: yvonne.alexander@4sc.com
Main Phone: +49 897007630
Address: Fraunhoferstrasse 22
City / Town: Planegg-Martinsried
Country: DEU
Postal Code: 82152

Issuer Information

Exchange: GREY
Employees: 44

Equities News

Profile

4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. The company's pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development: resminostat and domatinostat.

Contact Information

Website: www.4sc.com
Email: yvonne.alexander@4sc.com
Main Phone: +49 897007630
Address: Fraunhoferstrasse 22
City / Town: Planegg-Martinsried
Country: DEU
Postal Code: 82152

Issuer Information

Exchange: GREY
Employees: 44

Equities News

$ 5.30 $ 0. (0.00%)
Last Price 5.30 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 5.30
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 243.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,972,769.00 EPS (TTM) -0.67 PE Ratio N/A Exchange Greys